2 days ago
3
Attiya Zainib
Wed, May 13, 2026 astatine 4:27 AM CDT 3 min read
Minot Light Capital Partners, an concern absorption company, released its “Capital Appreciation Fund" Q1 2026 Investor Letter. A transcript of the missive tin beryllium downloaded here. The money declined by 2.7% successful the archetypal 4th of 2026 owed to a crisp macro-driven assemblage rotation pursuing geopolitical tensions, which triggered ostentation fears and rising involvement complaint expectations. This script led to a displacement successful capitalist absorption toward sectors specified arsenic energy, defense, and AI-linked stocks, portion the fund’s halfway vulnerability to healthcare, consumer, and idiosyncratic industrials lagged. Despite this setback, the steadfast maintains a constructive semipermanent outlook, suggesting that the existent marketplace volatility and consensus-driven marketplace narratives are creating charismatic opportunities successful out-of-favor sectors wherever it continues to find compelling valuations and expects eventual mean reversion to thrust aboriginal returns. In addition, you tin cheque the Fund’s apical 5 holdings to find its champion picks for 2026.
In its first-quarter 2026 capitalist letter, Minot Light Capital Appreciation Fund highlighted stocks similar MaxCyte, Inc. (NASDAQ:MXCT). MaxCyte, Inc. (NASDAQ:MXCT) is simply a cell-engineering institution providing electroporation exertion platforms for compartment therapy improvement and biomedical research. The one-month instrumentality of MaxCyte, Inc. (NASDAQ:MXCT) was -2.72% portion its shares traded betwixt $0.6434 and $2.4000 implicit the past 52 weeks. On May 12, 2026, MaxCyte, Inc. (NASDAQ:MXCT) banal closed astatine astir $0.82 per share, with a marketplace capitalization of astir $88.08 million.
Minot Light Capital Appreciation Fund stated the pursuing regarding MaxCyte, Inc. (NASDAQ:MXCT) in its Q1 2026 capitalist letter:
"When we look astatine our different apical detractors this quarters, you volition perceive a akin taxable astir erstwhile starring gainers becoming detractors aft large-stock runs and quarterly results that disappointed the Street. Another akin taxable is stocks falling good beneath what we deem to beryllium immoderate tenable valuation level, wherever we support adding to the presumption to marque it truly number erstwhile things turn. That would beryllium the lawsuit with MaxCyte, Inc. (NASDAQ:MXCT), which is simply a institution with a manageable existent pain rate, a starring presumption successful ex-vivo cistron editing equipment, and a bid of existent and hopefully aboriginal royalty streams associated with a fig of drugs being developed with its instrumentality and consumables. Shares of MaxCyte fell beneath fractional of nett currency connected the equilibrium expanse past quarter, which besides assigned nary worth to its halfway concern oregon aboriginal royalty cashflows. In turn, we person made it a top-five presumption for the fund."
English (CA) · 
English (US) · 
Spanish (MX) ·